PF-Atlas › Drugs › Lung-on-Chip

Lung-on-Chip

Idiopathic Pulmonary Fibrosis · Emulate Bio platform screens drug combinations in hours vs months

Mechanism
Emulate Bio platform screens drug combinations in hours vs months
Development stage
Available Now
Evidence level
Level 4 (Platform)
Developer
Wyss Institute / Emulate

Overview

IPF lung-on-chip recapitulates AEC2 dysfunction + fibroblast activation. Run 1000 combinations in parallel.

Explore related

Treatment profileEmulate Bio platform screens drug combinations in hours vs monthsAll trialsResearch
Medical disclaimer. This page summarizes research about Lung-on-Chip for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.